Twin Capital Management Inc Johnson & Johnson Transaction History

Twin Capital Management Inc

$827 Million
Q2 2024

A detailed history of Twin Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Twin Capital Management Inc holds 55,842 shares of JNJ stock, worth $9.28 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

55,842

Previous 55,215 1.14%

Holding current value

$9.28 Million

Previous $8.73 Million 6.56%

% of portfolio

0.99%

Previous 1.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $90,526 - $98,928	627 Added 1.14%	55,842 $8.16 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $405,279 - $424,914	-2,611 Reduced 4.52%	55,215 $8.73 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $178,796 - $195,104	-1,228 Reduced 2.08%	57,826 $9.06 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $96,097 - $107,654	617 Added 1.06%	59,054 $9.2 Million
Q2 2023 Aug 07, 2023	SELL	$154.35 - $166.11 $1.52 Million - $1.63 Million	-9,827 Reduced 14.4%	58,437 $9.67 Million
Q1 2023 May 08, 2023	SELL	$151.05 - $180.26 $2.54 Million - $3.03 Million	-16,802 Reduced 19.75%	68,264 $10.6 Million
Q4 2022 Jan 31, 2023	SELL	$160.2 - $179.79 $216,109 - $242,536	-1,349 Reduced 1.56%	85,066 $15 Million
Q3 2022 Oct 21, 2022	SELL	$161.33 - $179.52 $77,115 - $85,810	-478 Reduced 0.55%	86,415 $14.1 Million
Q2 2022 Aug 02, 2022	SELL	$168.19 - $186.01 $165,162 - $182,661	-982 Reduced 1.12%	86,893 $15.4 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $803,351 - $912,317	-5,080 Reduced 5.47%	87,875 $15.6 Million
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $1.02 Million - $1.13 Million	-6,530 Reduced 6.56%	92,955 $15.9 Million
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $1.86 Million - $2.06 Million	-11,489 Reduced 10.35%	99,485 $16.1 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $1.58 Million - $1.69 Million	9,876 Added 9.77%	110,974 $18.3 Million
Q1 2021 May 06, 2021	SELL	$153.07 - $170.48 $2.59 Million - $2.88 Million	-16,920 Reduced 14.34%	101,098 $16.6 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $2.24 Million - $2.57 Million	-16,339 Reduced 12.16%	118,018 $18.6 Million
Q3 2020 Nov 05, 2020	SELL	$140.38 - $153.83 $423,526 - $464,105	-3,017 Reduced 2.2%	134,357 $20 Million
Q2 2020 Aug 04, 2020	SELL	$128.81 - $155.51 $838,166 - $1.01 Million	-6,507 Reduced 4.52%	137,374 $19.3 Million
Q1 2020 Apr 29, 2020	SELL	$111.14 - $153.99 $125,588 - $174,008	-1,130 Reduced 0.78%	143,881 $18.9 Million
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $1.18 Million - $1.35 Million	-9,232 Reduced 5.99%	145,011 $21.2 Million
Q3 2019 Oct 28, 2019	SELL	$126.95 - $142.14 $291,985 - $326,921	-2,300 Reduced 1.47%	154,243 $20 Million
Q2 2019 Aug 01, 2019	SELL	$131.15 - $144.24 $8.33 Million - $9.17 Million	-63,549 Reduced 28.87%	156,543 $21.8 Million
Q1 2019 May 03, 2019	BUY	$125.72 - $139.79 $603,456 - $670,992	4,800 Added 2.23%	220,092 $30.8 Million
Q4 2018 Feb 04, 2019	BUY	$122.84 - $147.84 $1.84 Million - $2.21 Million	14,960 Added 7.47%	215,292 $27.8 Million
Q3 2018 Nov 08, 2018	SELL	$121.58 - $142.88 $613,735 - $721,258	-5,048 Reduced 2.46%	200,332 $27.7 Million
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $802,368 - $885,427	-6,720 Reduced 3.17%	205,380 $24.9 Million
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $8.13 Million - $9.62 Million	-64,960 Reduced 23.45%	212,100 $27.2 Million
Q4 2017 Jan 29, 2018	SELL	$131.22 - $143.62 $241,444 - $264,260	-1,840 Reduced 0.66%	277,060 $38.7 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $2.98 Million - $3.12 Million	23,010 Added 8.99%	278,900 $36.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	255,890	255,890 $33.9 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Johnson & Johnson Transaction History